How Elon Musk’s X Account Dominates the Platform Ahead of the Election
Read more at The New York Times
Topics
-
Elon Musk's America PAC Has Created an Election Denial Cesspool on X
Tech - Wired - 4 days ago -
Elon Musk’s ‘election integrity community’ on X is full of baseless claims
World - The Guardian - 4 days ago -
In Elon Musk's "election integrity" community on X, false claims proliferate
Top stories - CBS News - 3 days ago -
First Elon Musk changed Twitter to X — then he made it a MAGA haven
Top stories - NBC News - 4 days ago -
A Recent Timeline of Elon Musk Going All In on Trump
Tech - Wired - 17 hours ago -
Elon Musk's PAC Is Buying Ads for Donald Trump on Elon Musk's X
Tech - Wired - October 21 -
Elon Musk’s X is boosting election conspiracy theories with AI-powered trending topics
Top stories - NBC News - October 26 -
Middle East latest: Social platform X suspends new account on behalf of Iran's supreme leader
World - ABC News - October 28 -
How game developers win in a soft market dominated by big platforms
Tech - VentureBeat - October 18
More from The New York Times
-
Right-Wing Groups Are Organizing on Telegram Ahead of Election Day
Business - The New York Times - 8 hours ago -
Foreclosures in China Soar, Threatening to Choke Off Bank Profits
Business - The New York Times - 17 hours ago -
Can The Daily Beast Claw Its Way Back to Relevance?
Business - The New York Times - Yesterday -
Nobody Likes Doing Expense Reports. Why Isn’t It Easier?
Business - The New York Times - Yesterday -
New York Times Passes 11 Million Subscribers
Business - The New York Times - 8 hours ago
Latest in Business
-
Chinese equities outperform ahead of US election
Business - Financial Times - 1 hour ago -
Trump's tariffs could trigger 'dramatic' price spikes on clothes, furniture, warns retail group
Business - CNBC - 2 hours ago -
Palantir’s stock surges as AI drives a further acceleration in growth
Business - MarketWatch - 2 hours ago -
Marqeta’s stock may shed a third of its value as these factors spur weak outlook
Business - MarketWatch - 2 hours ago -
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
Business - MarketWatch - 2 hours ago